Showing results (911-920 of 1,241) with videos related to

Sort By:
Pageof 125
JACC. Heart Failure|September 1, 2022
Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of VericiguatPaul W Armstrong, Yinggan Zheng, Richard W Troughton, et al.
Circulation. Heart Failure|September 18, 2014
Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHEREPrateeti Khazanie, Bradley G Hammill, Laura G Qualls, et al.
Circulation. Heart Failure|January 1, 2015
Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart StudyRobert J Mentz, Melissa A Greiner, Adam D DeVore, et al.
Circulation. Cardiovascular Quality and Outcomes|April 9, 2018
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) RegistryYevgeniy Khariton, Adrian F Hernandez, Gregg C Fonarow, et al.
JACC. Heart Failure|June 2, 2018
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart FailureYevgeniy Khariton, Michael E Nassif, Laine Thomas, et al.
Vascular|December 4, 2018
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysisWilman Olmedo, Pedro A Villablanca, Cristina Sanina, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
American Heart Journal|March 8, 2017
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trialC Michael Gibson, Rim Halaby, Serge Korjian, et al.
Journal of the American Heart Association|November 4, 2024
Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health SystemsNishant P Shah, Hillary Mulder, Elizabeth Lydon, et al.
European Journal of Heart Failure|January 10, 2025
Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HFNina Nouhravesh, Alexander H Gunn, Derek Cyr, et al.
Pageof 125